Joseph Stringer
Stock Analyst at Needham
(4.47)
# 298
Out of 5,050 analysts
321
Total ratings
48.58%
Success rate
24.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $122 → $120 | $100.28 | +19.66% | 27 | Nov 7, 2025 | |
| CDTX Cidara Therapeutics | Maintains: Buy | $100 → $135 | $104.39 | +29.32% | 16 | Nov 7, 2025 | |
| GILD Gilead Sciences | Reiterates: Buy | $133 | $118.84 | +11.92% | 8 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $78 → $90 | $73.55 | +22.37% | 25 | Oct 30, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $65 | $69.84 | -6.93% | 19 | Oct 27, 2025 | |
| MRNA Moderna | Reiterates: Hold | n/a | $24.54 | - | 9 | Oct 20, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $22 → $35 | $22.86 | +53.11% | 24 | Oct 10, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $377 → $478 | $442.70 | +7.97% | 23 | Jul 31, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $28 | $13.25 | +111.32% | 52 | Jun 6, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $14 | $5.13 | +172.90% | 18 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $11 | $2.88 | +281.94% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $29 | $19.26 | +50.57% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $409.47 | - | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $41.65 | +116.09% | 17 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.25 | - | 13 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 | $1.60 | +525.00% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $22.57 | +63.93% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $14.75 | +22.03% | 2 | Aug 24, 2021 |
Rhythm Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $122 → $120
Current: $100.28
Upside: +19.66%
Cidara Therapeutics
Nov 7, 2025
Maintains: Buy
Price Target: $100 → $135
Current: $104.39
Upside: +29.32%
Gilead Sciences
Oct 31, 2025
Reiterates: Buy
Price Target: $133
Current: $118.84
Upside: +11.92%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $78 → $90
Current: $73.55
Upside: +22.37%
Avidity Biosciences
Oct 27, 2025
Downgrades: Hold
Price Target: $65
Current: $69.84
Upside: -6.93%
Moderna
Oct 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $24.54
Upside: -
Stoke Therapeutics
Oct 10, 2025
Maintains: Buy
Price Target: $22 → $35
Current: $22.86
Upside: +53.11%
Alnylam Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $377 → $478
Current: $442.70
Upside: +7.97%
Phathom Pharmaceuticals
Jun 6, 2025
Maintains: Buy
Price Target: $28
Current: $13.25
Upside: +111.32%
Vir Biotechnology
May 22, 2025
Reiterates: Buy
Price Target: $14
Current: $5.13
Upside: +172.90%
May 13, 2025
Maintains: Buy
Price Target: $16 → $11
Current: $2.88
Upside: +281.94%
May 7, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $19.26
Upside: +50.57%
May 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $409.47
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $90
Current: $41.65
Upside: +116.09%
Mar 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.25
Upside: -
Mar 4, 2025
Downgrades: Hold
Price Target: $10
Current: $1.60
Upside: +525.00%
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $22.57
Upside: +63.93%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $14.75
Upside: +22.03%